TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 122 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $5,852,000 | -17.5% | 75,000 | 0.0% | 0.15% | -29.4% |
Q1 2021 | $7,094,000 | -22.4% | 75,000 | 0.0% | 0.21% | -22.1% |
Q4 2020 | $9,139,000 | +39.5% | 75,000 | 0.0% | 0.27% | -7.5% |
Q3 2020 | $6,552,000 | +35.3% | 75,000 | 0.0% | 0.29% | +2.1% |
Q2 2020 | $4,844,000 | +44.6% | 75,000 | 0.0% | 0.29% | -19.4% |
Q1 2020 | $3,350,000 | -28.3% | 75,000 | 0.0% | 0.36% | -17.2% |
Q4 2019 | $4,672,000 | -99.8% | 75,000 | 0.0% | 0.43% | +47.3% |
Q3 2019 | $2,820,000,000 | +15.5% | 75,000 | +25.0% | 0.29% | +27.5% |
Q2 2019 | $2,442,000,000 | – | 60,000 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |